Circulating tumour-cell count used to decide between treatments for breast cancer patients from ctc free trial Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Dr Francois-Clement Bidard gives a press conference at SABCS 2018 about the results from the phase III STIC CTC trial, where circulating tumour-cell count was used to decide between hormone therapy or chemotherapy for patients with metastatic, ER+, HER2- breast cancer.nnWatch his interview with ecancer here: https://ecancer.org/conference/1122-sabcs-2018/video/7546/prognostic-value-of-circulating-tumour-cell-count-in-metastatic-breast-cancer-patients.phpnnRead more about this work. here: https:/
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)